Indication
Oligodendroglioma
Oligodendroglioma is a primary, diffusely infiltrating central nervous system neoplasm that arises from oligodendroglial lineage cells within the brain, most commonly affecting the cerebral hemispheres—particularly the frontal and temporal lobes—in young to middle-aged adults. Read more about Oligodendroglioma
1 drugs 1 manufacturers
Drugs that treat it
Common Oligodendroglioma therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonOligodendroglioma is a primary, diffusely infiltrating central nervous system neoplasm that arises from oligodendroglial lineage cells within the brain, most commonly affecting the cerebral hemispheres—particularly the frontal and temporal lobes—in young to middle-aged adults.
Under current World Health Organization classification criteria, it is defined pathologically by the mandatory co-occurrence of an isocitrate dehydrogenase (*IDH1* or *IDH2*) mutation and complete concurrent deletion of chromosome arms 1p and 19q (1p/19q codeletion).
Classified as either WHO grade 2 (low grade) or grade 3 (anaplastic), these tumors characteristically present with seizures, headaches, or focal neurologic deficits, exhibiting a classical "fried egg" cytomorphology on histology.
- nih.gov
Oligodendroglioma is a primary, diffusely infiltrating central nervous system neoplasm that arises from oligodendroglial lineage cells within the brain, most commonly affecting the cerebral hemispheres—particularly the frontal and temporal lobes—in young to middle-aged adults Classified as either WHO grade 2 (low grade) or grade 3 (anaplastic), these tumors characteristically present with seizures, headaches, or focal neurologic deficits, exhibiting a classical "fried egg" cytomorphology on hist...
- upmc.com
Oligodendroglioma is a primary, diffusely infiltrating central nervous system neoplasm that arises from oligodendroglial lineage cells within the brain, most commonly affecting the cerebral hemispheres—particularly the frontal and temporal lobes—in young to middle-aged adults
- columbia.edu
Oligodendroglioma is a primary, diffusely infiltrating central nervous system neoplasm that arises from oligodendroglial lineage cells within the brain, most commonly affecting the cerebral hemispheres—particularly the frontal and temporal lobes—in young to middle-aged adults
- clevelandclinic.org
Under current World Health Organization classification criteria, it is defined pathologically by the mandatory co-occurrence of an isocitrate dehydrogenase (*IDH1* or *IDH2*) mutation and complete concurrent deletion of chromosome arms 1p and 19q (1p/19q codeletion) Classified as either WHO grade 2 (low grade) or grade 3 (anaplastic), these tumors characteristically present with seizures, headaches, or focal neurologic deficits, exhibiting a classical "fried egg" cytomorphology on histology
- thebraintumourcharity.org
Under current World Health Organization classification criteria, it is defined pathologically by the mandatory co-occurrence of an isocitrate dehydrogenase (*IDH1* or *IDH2*) mutation and complete concurrent deletion of chromosome arms 1p and 19q (1p/19q codeletion)
- ars-neurochirurgica.com
Under current World Health Organization classification criteria, it is defined pathologically by the mandatory co-occurrence of an isocitrate dehydrogenase (*IDH1* or *IDH2*) mutation and complete concurrent deletion of chromosome arms 1p and 19q (1p/19q codeletion)
- cancer.gov
Classified as either WHO grade 2 (low grade) or grade 3 (anaplastic), these tumors characteristically present with seizures, headaches, or focal neurologic deficits, exhibiting a classical "fried egg" cytomorphology on histology
Personalize your experience
Follow Oligodendroglioma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.